لزوم ثبت اطلاعات فرآورده های فهرست پیوست در سامانه TTAC
به آگاهی میرساند؛ به پیوست نامه شماره ۳۹۳۵۸/ ۶۶۵ مورخ ۱۳ / ۰۷ / ۱۴۰۰ مدیر کل محترم دارو و مواد تحت کنترل در خصوص ثبت اطلاعات برخی از داروها در سامانه TTAC به استحضار می رساند ثبت تاییده دریافت و فروش برای داروهای موجود در لیست پیوست در سامانه TTAC به آدرس https://statisticsreports.ttac.ir از دسترسی "داروخانه" برای بیماران سرپایی و بستری از تاریخ این نامه اجباری بوده و در صورت عدم ثبت توسط داروخانه ها، از تحویل سهمیه بعدی توسط شرکت پخش به ایشان جلوگیری به عمل خواهد آمد.
در این راستا لازم است داروخانه اقدامات زیر را در دسترسی مربوطه با نام "ثبت نسخه الکترونیک اقلام سلامت محور" در سامانه انجام دهد:
۱. ثبت کد ملی و تاریخ تولد بیمار
۲. ثبت کد نظام پزشکی پزشک
۳. ثبت بارکد یا UID دارو
دارو |
ACTIVATED PROTHROMBIN COMPLEX (CONCENTRATED) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 1000 [iU] |
ACTIVATED PROTHROMBIN COMPLEX (CONCENTRATED) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 500 [iU] |
ADALIMUMAB INJECTION, SOLUTION PARENTERAL 50 mg/1mL 0.8 mL |
ANAGRELIDE HYDROCHLORIDE CAPSULE ORAL 500 ug |
ANTITHYMOCYTE IMMUNOGLOBULIN INJECTION PARENTERAL 50 mg/1mL 5 mL |
ANTITHYMOCYTE IMMUNOGLOBULIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 25 mg |
APOMORPHINE HYDROCHLORIDE INJECTION PARENTERAL 10 mg/1mL 3 mL |
APOMORPHINE HYDROCHLORIDE INJECTION PARENTERAL 5 mg/1mL 20 mL |
ASPARAGINASE 10,000U VIAL |
BEVACIZUMAB INJECTION, SOLUTION, CONCENTRATE PARENTERAL 25 mg/1mL 16 mL |
BEVACIZUMAB INJECTION, SOLUTION, CONCENTRATE PARENTERAL 25 mg/1mL 4 mL |
BORTEZOMIB INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 3.5 mg mg |
BUDESONIDE / FORMOTEROL FUMARATE POWDER, METERED RESPIRATORY 160 ug/4.5 ug/1{dose} 60 {dose} |
BUSULFAN TABLET ORAL 2 mg |
CALCIUM FOLINATE INJECTION PARENTERAL |
CICLOSPORIN INJECTION, SOLUTION INTRAVENOUS 50 mg/1mL 1 mL |
CICLOSPORIN INJECTION, SOLUTION INTRAVENOUS 50 mg/1mL 5 mL |
CICLOSPORIN SOLUTION ORAL 100 mg/1mL 50 mL |
CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION PARENTERAL 200 mg |
CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION PARENTERAL 500 mg |
CYCLOPHOSPHAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 1 g |
CYCLOPHOSPHAMIDE TABLET ORAL 50 mg |
DAPSONE TABLET ORAL 100 mg |
DEFEROXAMINE MESYLATE INJECTION, POWDER, FOR SOLUTION PARENTERAL 500 mg |
DIAZOXIDE 100MG CAP |
DIAZOXIDE 50MG cap |
ENOXAPARIN SODIUM INJECTION PARENTERAL 100 mg/1mL |
EPHEDRINE HCL 30MG TAB |
ESTRAMUSTINE SODIUM PHOSPHATE CAPSULE ORAL 140 mg |
ETANERCEPT INJECTION, SOLUTION SUBCUTANEOUS 25 mg/0.5mL |
ETANERCEPT INJECTION, SOLUTION SUBCUTANEOUS 50 mg/1mL 1 mL |
ETHIODIZED OIL INJECTION PARENTERAL 10 mL |
ETOPOSIDE 100MG CAP |
ETOPOSIDE 50MG CAP |
ETOPOSIDE INJECTION, SOLUTION INTRAVENOUS 20 mg/1mL 5 mL |
EVEROLIMUS TABLET ORAL 0.25 mg |
EVEROLIMUS TABLET ORAL 0.75 mg |
EVEROLIMUS TABLET ORAL 10 mg |
EVEROLIMUS TABLET ORAL 5 mg |
EVOLOCUMAB INJECTION PARENTERAL 140 mg/1mL |
FACTOR IX INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 1000 [iU] |
FACTOR VIII / VON WILLEBRAND FACTOR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 500 [iU]/1200 [iU] |
FACTOR VIII / VON WILLEBRAND FACTOR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 500 [iU]/500 [iU] |
FACTOR XIII INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 250 [iU] |
FIBRINOGEN INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g |
FORMOTEROL FUMARATE CAPSULE RESPIRATORY 12 ug |
GADOBUTROL INJECTION PARENTERAL 604.72 mg/1mL 15 mL |
GADOBUTROL INJECTION PARENTERAL 604.72 mg/1mL 7.5 mL |
GOSERELIN ACETATE IMPLANT PARENTERAL 10.8 mg |
GOSERELIN ACETATE IMPLANT PARENTERAL 3.6 mg |
INFLIXIMAB INJECTION, POWDER, FOR SOLUTION PARENTERAL 100 mg |
INTERFERON BETA-1A INJECTION PARENTERAL 12000000 [iU] 0.5 mL |
IRON (AS SUCROSE) INJECTION INTRAVENOUS 20 mg/1mL 5 mL |
ISOPROTERENOL INJECTION, 0.2 MG/ML |
LIRAGLUTIDE INJECTION, SOLUTION PARENTERAL 6 mg/1mL 3 mL |
MELPHALAN 50MG VIAL |
METHYLENE BLUE INJECTION PARENTERAL 10 mg/1mL 5 mL |
MILRINONE LACTATE INJECTION, SOLUTION PARENTERAL 1 mg/1mL 10 mL |
MINOXIDIL 10MG TAB |
MITOTANE 500MG TAB |
MYCOPHENOLATE MOFETIL TABLET ORAL 250 mg |
MYCOPHENOLATE MOFETIL TABLET ORAL 500 mg |
MYCOPHENOLIC ACID TABLET, DELAYED RELEASE ORAL 360 mg |
NATALIZUMAB INJECTION, SOLUTION, CONCENTRATE PARENTERAL 20 mg/1mL 15 mL |
NATAMYCIN 5% OPH DROP |
NIMODIPINE 30 MG TAB |
NOREPINEPHRINE (AS BITARTRATE) INJECTION PARENTERAL 0.1 % 10 mL |
NOREPINEPHRINE (AS BITARTRATE) INJECTION PARENTERAL 0.1 % 4 mL |
OMALIZUMAB 150MG INJECTION |
PANITUMUMAB INJECTION, SOLUTION, CONCENTRATE PARENTERAL 20 mg/1mL 20 mL |
PANITUMUMAB INJECTION, SOLUTION, CONCENTRATE PARENTERAL 20 mg/1mL 5 mL |
PAPAVERINE HCL 40MG/ML AMP |
POSACONAZOLE INJECTION, SOLUTION, CONCENTRATE PARENTERAL 300 mg/16.7mL |
POSACONAZOLE SUSPENSION ORAL 40 mg/1mL 105 mL |
PROPAFENONE HCL 150MG TAB |
PROPAFENONE HCL 300MG TAB |
RASBURICASE INJECTION, POWDER, FOR SOLUTION PARENTERAL 1.5 mg |
RITUXIMAB INJECTION PARENTERAL |
SIROLIMUS TABLET ORAL 1 mg |
SPECTINOMYCIN INJECTION, POWDER, FOR SOLUTION PARENTERAL 2 g |
SPIRAMYCIN 500MG TAB |
STREPTOMYCIN INJECTION 1 g |
TACROLIMUS CAPSULE ORAL 0.5 mg |
TACROLIMUS CAPSULE ORAL 1 mg |
THIOPENTAL SODIUM INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g -500 |
VERTEPORFIN (VISUDYNE) |
VIGABATRIN TABLET ORAL 500 mg |
VINBLASTINE SULFATE INJECTION, POWDER, FOR SOLUTION PARENTERAL 10 mg |
VINCRISTINE SULFATE INJECTION PARENTERAL 1 mg/1mL |
نظر شما :